George Ngwa has a diverse work experience in the pharmaceutical industry. George started their career as a Research Chemist at OraSure Technologies, where they developed and validated analytical methods for various substances. George then worked at Particle Science as a Senior Analytical Chemist, focusing on method development and regulatory compliance. After that, they joined Axcentria Pharmaceuticals as an Analytical Manager, overseeing the analytical laboratory and collaborating with other departments to improve production efficiency. George also worked as a Supervisor at BBraun Medical Inc., managing chemical and LAL testing. George then joined CAPS Pharmacy as a QA Manager and later became the Director of Quality. In their current position as the Regional Director of Quality at CAPS (Central Admixture Pharmacy Services, Inc.), George continues to oversee quality assurance and ensure regulatory compliance.
George Ngwa obtained their Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry from Lehigh University between 2002 and 2007. George also pursued a Master of Business Administration (MBA) in Healthcare Management from Western Governors University, but the start and end years are unknown. Additionally, George Ngwa attended the University of Buea, but their degree and field of study are unspecified.
CAPS® (Central Admixture Pharmacy Services, Inc.)
1 followers
CAPS®, the nation's largest network of outsourcing admixture pharmacies, has been delivering high-quality, same-day, admixture services and solutions to hospitals and outpatient facilities for more than 28 years. Along with the nation’s largest 503A network, CAPS offers industry-leading batch compounding on a national scale through three 503B-registered outsourcing facilities. With experience, capacity, and a passion for safety, CAPS is your 503B solution. CAPS is part of the B. Braun Group of Companies in the U.S.